VYNE Therapeutics Inc. (VYNE) Q3 2021 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning, and welcome to the Vine Therapeutics conference call to discuss the third quarter 2021 financial results and corporate update. At this time, all participants are in a listen-only mode, and following the company's formal remarks, we will open the call for your questions. Please be advised that this call is being recorded at the company's request. I will now turn the call over to John Francis of LifeSci Advisors. Please go ahead. Good morning, everyone, and thank you for joining us. Participating in this morning's call are Dave Domzalski, Vine's President and Chief Executive Officer, Tyler Zaranda, Vine's Chief Financial Officer, and Dr. Ian Stewart, the company's Chief Scientific Officer. Please note that there are slides to accompany Dr. Stewart's discussion. For those of you dialed into the phone lines, in order to access these slides, you will need to log on to the live webcast. The link can be found on the Investors and Media section of Vine's corporate website under Events and Presentation. Slide presentation and a replay of this conference call will be archived on the company's website. Before we begin formal remarks, let me remind you that some of the information in the press release issued this morning and on this conference call contain forward-looking statements that involve risks, uncertainties, and assumptions that are difficult to predict, including statements regarding Vine's development programs and future plans and prospects, as well as observations regarding ongoing operating expenses. These statements will include plans and expectations regarding strategic transactions, and the success, timing, and cost of clinical trials. Words that express and reflect optimism, satisfaction with current progress, prospects or projections, as well as w...